Arcturus therapeutics holdings inc. (ARCT)
Income statement / Yearly
Dec'19Dec'18
Collaboration revenue

20,789

15,753

Operating expenses:
Research and development, net

33,640

16,982

General and administrative

12,662

20,582

Total operating expenses

46,302

37,564

Loss from operations

-25,513

-21,811

Loss from equity-method investment

-32

-302

Finance expense, net

-446

328

Net loss

-25,991

-21,785

Net loss per share, basic and diluted

-2.15

-2.16

Weighted-average shares outstanding, basic and diluted

12,069

10,069

Comprehensive loss:
Net loss

-25,991

-21,785

Unrealized gain on short-term investments

-

3

Comprehensive loss

-25,991

-21,782